Current Report Filing (8-k)
06 November 2019 - 10:03PM
Edgar (US Regulatory)
0000203527
false
0000203527
2019-10-31
2019-11-01
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported)
|
November 1, 2019
|
VARIAN MEDICAL SYSTEMS, INC.
|
(Exact Name of Registrant as Specified in its Charter)
|
Delaware
|
1-7598
|
94-2359345
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File
Number)
|
(IRS Employer
Identification No.)
|
3100 Hansen Way, Palo Alto, CA
|
94304-1030
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant's telephone number, including area code
|
(650) 493-4000
|
Not Applicable
|
(Former Name or Former Address, if Changed Since Last Report)
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ¨
Securities registered pursuant to Section 12(b) of the Act:
Title of each class:
|
Trading Symbol(s)
|
Name of each exchange on which registered:
|
Common Stock, $1 par value
|
VAR
|
New York Stock Exchange
|
|
Item 1.01.
|
Entry Into a Material Definitive Agreement.
|
On
November 1, 2019, Varian Medical Systems, Inc. (the "Company") entered into the Amendment No. 2 to Credit Agreement (the
“Amendment”) to its Credit Agreement dated as of April 3, 2018 (the “Credit Agreement”), by and among the
Company, certain lenders party thereto, and Bank of America, N.A., as administrative agent, swing line lender and letter of credit
issuer. The Amendment, among other things, reduces the aggregate principal amount available under the revolving credit facility
provided under the Credit Agreement from $1.8 billion to $1.2 billion, reduces the commitment fee, adds a $500 million sublimit
for multi-currency borrowings, increases the letter of credit sublimit to $225 million, extends the maturity date from April 2023
to November 2024 and adds BNP Paribas and Goldman Sachs to the lender group.
For
a summary of other terms of the Credit Agreement, please see our Form 8-K Current Report filed as of April 4, 2018, File No. 1-7598.
|
Item 2.03.
|
Creation of a Direct Financial Obligation or an Obligation
'under an Off-Balance Sheet Arrangement of a Registrant.
|
The
response to this item is set forth in Item 2.01 above and is by this reference incorporated herein.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Varian Medical Systems, Inc.
|
|
|
|
By:
|
/s/ John W. Kuo
|
|
Name:
Title:
|
John W. Kuo
Senior Vice President, General Counsel and Corporate Secretary
|
Dated: November 5, 2019
Varian Medical System (NYSE:VAR)
Historical Stock Chart
From Apr 2024 to May 2024
Varian Medical System (NYSE:VAR)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Varian Medical System (New York Stock Exchange): 0 recent articles
More Varian Medical Systems Inc News Articles